We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Myomo Inc is a medical robotics company. It develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. Myomo develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened a... Myomo Inc is a medical robotics company. It develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. Myomo develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuro-muscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The company's products are referred to patients at leading rehabilitation facilities, including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Kennedy Krieger Institute, Loma Linda Medical Center and twenty VA hospitals, among others. Show more
Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today...
Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today...
$9.2 million in revenue, raises full-year revenue guidance 225 MyoPro® authorizations and orders with 316 patients in backlog at quarter end 645 additions to the pipeline result in 1,263 patients...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.87 | -12.6637554585 | 6.87 | 7.1699 | 5.984 | 939698 | 6.89510788 | CS |
4 | -0.1 | -1.6393442623 | 6.1 | 7.1699 | 5.48 | 419067 | 6.5712735 | CS |
12 | 2.27 | 60.8579088472 | 3.73 | 7.1699 | 3.59 | 309416 | 5.81926374 | CS |
26 | 1.32 | 28.2051282051 | 4.68 | 7.1699 | 3.59 | 276223 | 5.09588793 | CS |
52 | 1.96 | 48.5148514851 | 4.04 | 7.1699 | 2.52 | 321986 | 4.31928792 | CS |
156 | -2.22 | -27.0072992701 | 8.22 | 8.78 | 0.369 | 396626 | 2.13124376 | CS |
260 | 5.66 | 1664.70588235 | 0.34 | 40 | 0.2699 | 384904 | 4.02607194 | CS |
Symbol | Price | Vol. |
---|---|---|
KAPAKairos Pharma Ltd | US$ 2.16 (122.68%) | 113.54M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6.445 (-0.23%) | 90.34M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27.85 (-0.75%) | 68.29M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2.41 (-4.17%) | 55.74M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3.29 (3.95%) | 50.41M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions